Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    Three new June 2026 press release headlines were added to the News releases list, updating the page with the latest company announcements. Older entries from May and April 2026 were removed from the listing.
    Difference
    6%
    Check dated 2026-06-08T05:29:02.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Three new May 2026 items are added (May 29, May 28, and May 26). Several April 2026 entries are removed, updating the list of current company updates.
    Difference
    6%
    Check dated 2026-06-01T04:50:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Two new news releases were added to the listing on May 22, 2026 and May 18, 2026, highlighting Merck's latest regulatory and trial updates. An older release from April 20, 2026 was removed from the listing.
    Difference
    6%
    Check dated 2026-05-25T05:54:04.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A new news release about Merck's ASCO 2026 data was added to the News releases list. A previously published release announcing the European Commission's RSV approval for ENFLONSIA was removed.
    Difference
    5%
    Check dated 2026-05-18T03:42:52.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Two new news releases were added to the News releases feed: Merck Scientists Publish Landmark Paper on Novel Method for Large-Scale Biocatalytic Synthesis of Investigational Oral PCSK9 Inhibitor, Enlicitide Decanoate; Merck Completes Acquisition of Terns Pharmaceuticals, Inc. Two older releases were removed from the feed: Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy; Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.
    Difference
    6%
    Check dated 2026-05-10T22:18:24.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Two new Merck news releases were added to the News releases feed: April 30, 2026 announcing Merck's first-quarter 2026 financial results with regulatory milestones, and April 28, 2026 about the Playing with Heart program with baseball clubs to raise LDL-C awareness. The feed also removed two older items dated April 2, 2026—the Phase 2b/3 trial initiation for MK-8748 and the European Commission's decision on a KEYTRUDA-based treatment.
    Difference
    6%
    Check dated 2026-05-03T13:40:46.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.